Article
Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study.
Surgical oncology - 1 Sept 2018
Korkmaz Levent, Coşkun Hasan Şenol, Dane Faysal, Karabulut Bülent, Karaağaç Mustafa, Çabuk Devrim, Karabulut Senem, Aykan Nuri Faruk, Doruk Hatice, Avcı Nilüfer, Turhal Nazım Serdar, Artaç Mehmet
Abstract excerpt
PURPOSE: We aimed to investigate the prognostic effect of primary tumor resection (PTR) prior to bevacizumab-based treatments in unresectable metastatic colorectal cancer (mCRC). METHODS: We retrospectively collected 341 mCRC cases with unresectable metastases at diagnosis. PTR was performed in 210 cases (the surgery group) and the other patients (n = 131) were followed without PTR (the no-surgery group). All the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
